Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) was down 5% during mid-day trading on Friday . The company traded as low as GBX 1.71 ($0.02) and last traded at GBX 1.71 ($0.02). Approximately 14,853 shares changed hands during mid-day trading, a decline of 99% from the average daily volume of 1,188,235 shares. The stock had previously closed at GBX 1.80 ($0.02).
Cizzle Biotechnology Stock Performance
The company’s 50-day moving average price is GBX 1.93 and its 200 day moving average price is GBX 1.85. The stock has a market capitalization of £6.78 million, a P/E ratio of -171.00 and a beta of 0.38.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Further Reading
- Five stocks we like better than Cizzle Biotechnology
- Health Care Stocks Explained: Why You Might Want to Invest
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- Stock Average Calculator
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to Calculate Inflation Rate
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
